Floatz logo

8 assets in Skin Neoplasm

Therapeutic assets addressing Skin Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Pertuzumab
Skin Neoplasm
Cancer Research UKP2/3B (57)
Trastuzumab
Skin Neoplasm
Cancer Research UKP2/3B (57)
Obx-115
Skin Neoplasm
Obsidian Therapeutics, Inc.P1/2CCC (48)
Jcxh-211
Skin Neoplasm
Immorna Biotherapeutics, Inc.P1CC (47)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Skin Neoplasm
Ankyra Therapeutics, IncP1CC (43)
mq719
Skin Neoplasm
Memorial Sloan Kettering Cancer CenterP1CC (43)
Pembrolizumab
Skin Neoplasm
Memorial Sloan Kettering Cancer CenterP1CC (43)
Tolododekin Alfa
Skin Neoplasm
Ankyra Therapeutics, IncP1CC (43)